IMRX stock jumps on IND filing for lead cancer candidate (NASDAQ:IMRX)
Immuneering seeks FDA nod to conduct clinical trial for lead cancer candidate
Quoted from Various Sources
Published for: Ipodifier
iPodifier
Beyond Business
Beyond Business
Immuneering seeks FDA nod to conduct clinical trial for lead cancer candidate
Quoted from Various Sources
Published for: Ipodifier
